BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4053602)

  • 1. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.
    Guha SK; Ansari S; Anand S; Farooq A; Misro MM; Sharma DN
    Contraception; 1985 Jul; 32(1):109-18. PubMed ID: 4053602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-vas deferens injection of styrene maleic anhydride gel for male contraception: is it safe?
    Singh AK
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):208-9. PubMed ID: 12419065
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical toxicity study of a male injectable antifertility agent (styrene maleic anhydride) in rhesus monkeys, Macaca mulatta.
    Sethi N; Srivastava RK; Nath D; Singh RK
    J Med Primatol; 1991; 20(2):89-93. PubMed ID: 1865485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats.
    Koul V; Srivastav A; Guha SK
    Contraception; 1998 Oct; 58(4):227-31. PubMed ID: 9866004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus).
    Lohiya NK; Manivannan B; Mishra PK; Pathak N; Balasubramanian SP
    Contraception; 1998 Aug; 58(2):119-28. PubMed ID: 9773267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive reversal of intraluminal vas deferens polymer injection-induced azoospermia--technology.
    Guha SK
    Asian J Androl; 1999 Sep; 1(3):131-4. PubMed ID: 11250780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable non-occlusive chemical contraception in the male-I.
    Misro M; Guha SK; Singh H; Mahajan S; Ray AR; Vasudevan P
    Contraception; 1979 Nov; 20(5):467-73. PubMed ID: 43211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety evaluation of a male injectable antifertility agent, styrene maleic anhydride, in rats.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1989 Feb; 39(2):217-26. PubMed ID: 2706990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys.
    Lohiya NK; Manivannan B; Mishra PK
    Int J Androl; 2000 Feb; 23(1):36-42. PubMed ID: 10632760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive.
    Verma K; Misro MM; Singh H; Mahajan S; Ray AR; Guha SK
    J Reprod Fertil; 1981 Nov; 63(2):539-42. PubMed ID: 7299756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
    Guha SK
    Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mode of contraception using polymeric hydrogels. I.
    Singh H; Vasudevan P; Misro M; Ray AR; Guha SK
    J Biomed Mater Res; 1982 Jan; 16(1):3-9. PubMed ID: 7056760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural changes in the spermatozoa of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride.
    Lohiya NK; Manivannan B; Mishra PK
    Contraception; 1998 Feb; 57(2):125-32. PubMed ID: 9589840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial of an injectable contraceptive for the male.
    Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
    Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience.
    Sharma RS; Mathur AK; Singh R; Das HC; Singh GJ; Toor DPS; Guha SK
    Indian J Med Res; 2019 Jul; 150(1):81-86. PubMed ID: 31571633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic toxicity of styrene maleic anhydride, a male contraceptive, in rhesus monkeys (Macaca mulatta).
    Sethi N; Srivastava RK; Singh RK; Bhatia GS; Sinha N
    Contraception; 1990 Sep; 42(3):337-47. PubMed ID: 2289393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-controlled injectable occlusion of the vas deferens.
    Guha SK; Anand S; Ansari S; Farooq A; Sharma DN
    Contraception; 1990 Mar; 41(3):323-31. PubMed ID: 2323220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive.
    Guha SK
    Asian J Androl; 2007 Mar; 9(2):221-7. PubMed ID: 17334590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural changes in the vas deferens of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride and after its reversal.
    Manivannan B; Mishra PK; Lohiya NK
    Contraception; 1999 Feb; 59(2):137-44. PubMed ID: 10361629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.